|
1
|
Aldape K, Zadeh G, Mansouri S,
Reifenberger G and von Deimling A: Glioblastoma: Pathology,
molecular mechanisms and markers. Acta Neuropathol. 129:829–848.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kanu OO, Hughes B, Di C, Lin N, Fu J,
Bigner DD, Yan H and Adamson C: Glioblastoma multiforme
oncogenomics and signaling pathways. Clin Med Oncol. 3:39–52.
2009.PubMed/NCBI
|
|
3
|
Cloughesy TF, Cavenee WK and Mischel PS:
Glioblastoma: From molecular pathology to targeted treatment. Annu
Rev Pathol. 9:1–25. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Carlsson SK, Brothers SP and Wahlestedt C:
Emerging treatment strategies for glioblastoma multiforme. EMBO Mol
Med. 6:1359–1370. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lapointe S, Perry A and Butowski NA:
Primary brain tumours in adults. Lancet. 392:432–446. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chan JJ and Tay Y: Noncoding RNA:RNA
regulatory networks in cancer. Int J Mol Sci. 19:13102018.
View Article : Google Scholar
|
|
7
|
Floyd D and Purow B: Micro-masters of
glioblastoma biology and therapy: Increasingly recognized roles for
microRNAs. Neuro Oncol. 16:622–627. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Slack FJ and Chinnaiyan AM: The role of
Non-coding RNAs in oncology. Cell. 179:1033–1055. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang J, Yang Y, Yang T, Yuan S, Wang R,
Pan Z, Yang Y, Huang G, Gu F, Jiang B, et al: Double-negative
feedback loop between microRNA-422a and forkhead box (FOX)G1/Q1/E1
regulates hepatocellular carcinoma tumor growth and metastasis.
Hepatology. 61:561–573. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu L, Hu B, Zhao B, Liu Y, Yang Y, Zhang L
and Chen J: Circulating microRNA-422a is associated with lymphatic
metastasis in lung cancer. Oncotarget. 8:42173–42188. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zheng G, Du L, Yang X, Zhang X, Wang L,
Yang Y, Li J and Wang C: Serum microRNA panel as biomarkers for
early diagnosis of colorectal adenocarcinoma. Br J Cancer.
111:1985–1992. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hong X, Liu N, Liang Y, He Q, Yang X, Lei
Y, Zhang P, Zhao Y, He S, Wang Y, et al: Circular RNA CRIM1
functions as a ceRNA to promote nasopharyngeal carcinoma metastasis
and docetaxel chemoresistance through upregulating FOXQ1. Mol
Cancer. 19:332020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Du S, Wang S, Zhang F and Lv Y: SKP2,
positively regulated by circ_ODC1/miR-422a axis, promotes the
proliferation of retinoblastoma. J Cell Biochem. 121:322–331. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liang H, Wang R, Jin Y, Li J and Zhang S:
MiR-422a acts as a tumor suppressor in glioblastoma by targeting
PIK3CA. Am J Cancer Res. 6:1695–1707. 2016.PubMed/NCBI
|
|
15
|
Lemjabbar-Alaoui H, McKinney A, Yang YW,
Tran VM and Phillips JJ: Glycosylation alterations in lung and
brain cancer. Adv Cancer Res. 126:305–344. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ono M, Tsuda H, Kobayashi T, Takeshita F,
Takahashi RU, Tamura K, Akashi-Tanaka S, Moriya T, Yamasaki T,
Kinoshita T, et al: The expression and clinical significance of
ribophorin II (RPN2) in human breast cancer. Pathol Int.
65:301–308. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Veillon L, Fakih C, Abou-El-Hassan H,
Kobeissy F and Mechref Y: Glycosylation changes in brain cancer.
ACS Chem Neurosci. 9:51–72. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fujimoto D, Goi T, Koneri K and Hirono Y:
RPN2 is effective biomarker to predict the outcome of combined
chemotherapy docetaxel and cisplatin for advanced gastric cancer.
Oncotarget. 9:15208–15218. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fujiwara T, Takahashi RU, Kosaka N, Nezu
Y, Kawai A, Ozaki T and Ochiya T: RPN2 gene confers osteosarcoma
cell malignant phenotypes and determines clinical prognosis. Mol
Ther Nucleic Acids. 3:e1892014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang J, Yan B, Spath SS, Qun H, Cornelius
S, Guan D, Shao J, Hagiwara K, Van Waes C, Chen Z, et al:
Integrated transcriptional profiling and genomic analyses reveal
RPN2 and HMGB1 as promising biomarkers in colorectal cancer. Cell
Biosci. 5:532015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhao Z, Meng F, Wang W, Wang Z, Zhang C
and Jiang T: Comprehensive RNA-seq transcriptomic profiling in the
malignant progression of gliomas. Sci Data. 4:1700242017.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tang Z, Kang B, Li C, Chen T and Zhang Z:
GEPIA2: An enhanced web server for large-scale expression profiling
and interactive analysis. Nucleic Acids Res. 47((W1)): W556–W560.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chandrashekar DS, Bashel B, Balasubramanya
SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK and
Varambally S: UALCAN: A portal for facilitating tumor subgroup gene
expression and survival analyses. Neoplasia. 19:649–658. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sun J, Jia Z, Li B, Zhang A, Wang G, Pu P,
Chen Z, Wang Z and Yang W: MiR-19 regulates the proliferation and
invasion of glioma by RUNX3 via β-catenin/Tcf-4 signaling.
Oncotarget. 8:110785–110796. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
He Z, Li Z, Zhang X, Yin K, Wang W, Xu Z,
Li B, Zhang L, Xu J, Sun G, et al: MiR-422a regulates cellular
metabolism and malignancy by targeting pyruvate dehydrogenase
kinase 2 in gastric cancer. Cell Death Dis. 9:5052018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang H, He QY, Wang GC, Tong DK, Wang RK,
Ding WB, Li C, Wei Q, Ding C, Liu PZ, et al: miR-422a inhibits
osteosarcoma proliferation by targeting BCL2L2 and KRAS. Biosci
Rep. 38:BSR201703392018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li R, Gao K, Luo H, Wang X, Shi Y, Dong Q,
Luan W and You Y: Identification of intrinsic subtype-specific
prognostic microRNAs in primary glioblastoma. J Exp Clin Cancer
Res. 33:92014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Maris C, D'Haene N, Trepant AL, Le Mercier
M, Sauvage S, Allard J, Rorive S, Demetter P, Decaestecker C and
Salmon I: IGF-IR: A new prognostic biomarker for human
glioblastoma. Br J Cancer. 113:729–737. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang H, Tang C, Na M, Ma W, Jiang Z, Gu Y,
Ma G, Ge H, Shen H and Lin Z: miR-422a inhibits glioma
proliferation and invasion by targeting IGF1 and IGF1R. Oncol Res.
25:187–194. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
De Souza R, Zahedi P, Badame RM, Allen C
and Piquette- Miller M: Chemotherapy dosing schedule influences
drug resistance development in ovarian cancer. Mol Cancer Ther.
10:1289–1299. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Honma K, Iwao-Koizumi K, Takeshita F,
Yamamoto Y, Yoshida T, Nishio K, Nagahara S, Kato K and Ochiya T:
RPN2 gene confers docetaxel resistance in breast cancer. Nat Med.
14:939–948. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kurashige J, Watanabe M, Iwatsuki M,
Kinoshita K, Saito S, Nagai Y, Ishimoto T, Baba Y, Mimori K and
Baba H: RPN2 expression predicts response to docetaxel in
oesophageal squamous cell carcinoma. Br J Cancer. 107:1233–1238.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang H, Jiang H, Zhang H, Liu J, Hu X and
Chen L: Ribophorin II potentiates P-glycoprotein- and
ABCG2-mediated multidrug resistance via activating ERK pathway in
gastric cancer. Int J Biol Macromol. 128:574–582. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Koshkin PA, Chistiakov DA, Nikitin AG,
Konovalov AN, Potapov AA, Usachev DY, Pitskhelauri DI, Kobyakov GL,
Shishkina LV and Chekhonin VP: Analysis of expression of microRNAs
and genes involved in the control of key signaling mechanisms that
support or inhibit development of brain tumors of different grades.
Clin Chim Acta. 430:55–62. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Stavrovskaya AA, Shushanov SS and
Rybalkina EY: Problems of glioblastoma multiforme drug resistance.
Biochemistry (Mosc). 81:91–100. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang K, Zhang J, Han L, Pu P and Kang C:
Wnt/beta-catenin signaling in glioma. J Neuroimmune Pharmacol.
7:740–749. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
He L, Zhou H, Zeng Z, Yao H, Jiang W and
Qu H: Wnt/β-catenin signaling cascade: A promising target for
glioma therapy. J Cell Physiol. 234:2217–2228. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lim JC, Kania KD, Wijesuriya H, Chawla S,
Sethi JK, Pulaski L, Romero IA, Couraud PO, Weksler BB, Hladky SB
and Barrand MA: Activation of beta-catenin signalling by GSK-3
inhibition increases p-glycoprotein expression in brain endothelial
cells. J Neurochem. 106:1855–1865. 2008.PubMed/NCBI
|
|
40
|
Takahashi RU, Takeshita F, Honma K, Ono M,
Kato K and Ochiya T: Ribophorin II regulates breast tumor
initiation and metastasis through the functional suppression of
GSK3β. Sci Rep. 3:24742013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Low SY, Ho YK, Too HP, Yap CT and Ng WH:
MicroRNA as potential modulators in chemoresistant high-grade
gliomas. J Clin Neurosci. 21:395–400. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Novakova J, Slaby O, Vyzula R and Michalek
J: MicroRNA involvement in glioblastoma pathogenesis. Biochem
Biophys Res Commun. 386:1–5. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Xin S, Huang K and Zhu XG: Non-coding
RNAs: Regulators of glioma cell epithelial-mesenchymal
transformation. Pathol Res Pract. 215:1525392019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhang X, Gao D, Fang K, Guo Z and Li L:
Med19 is targeted by miR-101-3p/miR-422a and promotes breast cancer
progression by regulating the EGFR/MEK/ERK signaling pathway.
Cancer Lett. 444:105–115. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Li WQ, Zhang JP, Wang YY, Li XZ and Sun L:
MicroRNA-422a functions as a tumor suppressor in non-small cell
lung cancer through SULF2-mediated TGF-β/SMAD signaling pathway.
Cell Cycle. 18:1727–1744. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wei WT, Nian XX, Wang SY, Jiao HL, Wang
YX, Xiao ZY, Yang RW, Ding YQ, Ye YP and Liao WT: miR-422a inhibits
cell proliferation in colorectal cancer by targeting AKT1 and
MAPK1. Cancer Cell Int. 17:912017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Huang L, Jian Z, Gao Y, Zhou P, Zhang G,
Jiang B and Lv Y: RPN2 promotes metastasis of hepatocellular
carcinoma cell and inhibits autophagy via STAT3 and NF-KB pathways.
Aging (Albany NY). 11:6674–6690. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Dragomir M, Mafra ACP, Dias SMG, Vasilescu
C and Calin GA: Using microRNA networks to understand cancer. Int J
Mol Sci. 19:18712018. View Article : Google Scholar
|
|
49
|
Zhou Z, Lin Z, He Y, Pang X, Wang Y,
Ponnusamy M, Ao X, Shan P, Tariq MA, Li P and Wang J: The long
noncoding RNA D63785 regulates chemotherapy sensitivity in human
gastric cancer by targeting miR-422a. Mol Ther Nucleic Acids.
12:405–419. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Wang R, Zhang S, Chen X, Li N, Li J, Jia
R, Pan Y and Liang H: CircNT5E Acts as a Sponge of miR-422a to
promote glioblastoma tumorigenesis. Cancer Res. 78:4812–4825. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Wei F, Yang L, Jiang D, Pan M, Tang G,
Huang M and Zhang J: Long noncoding RNA DUXAP8 contributes to the
progression of hepatocellular carcinoma via regulating
miR-422a/PDK2 axis. Cancer Med. 9:2480–2490. 2020. View Article : Google Scholar : PubMed/NCBI
|
